Teva Wins Ruling on Patents for Bendeka Cancer Drug

(Bloomberg) -- Teva Pharmaceutical Industries Ltd. won a ruling that could keep its cancer drug Bendeka free from generic competition for more than a decade.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.